Refine by
Cardiac Care Articles & Analysis: Older
14 news found
By deepening our relationship with AWS, we can help even more clinicians improve cardiac care by delivering cutting-edge solutions that enable more efficient and effective remote monitoring,” said Jon Hunt, PhD., Implicity’s Chief Commercial Officer in North America. Implicity’s AI-powered* platform allows healthcare professionals to better ...
“Bodyport is pioneering an incredibly intuitive care management platform to make a meaningful difference in the quality of care for patient’s ...
(NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the Zio Watch. ...
A range of topics spanning from continuing to care for patients during a pandemic to screening for asymptomatic atrial fibrillation are available. Evidence illustrating how the Zio service has helped healthcare systems improve cardiac patient care can be found in the case studies section of the CRC. ...
“These results represent an exciting development in cardiac arrhythmia care and a significant step forward for the EP community in being able to better understand where arrhythmia sources are located,” said Dr. ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces its participation in two upcoming investor conferences. ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has registered a new subsidiary, CytoSorbents Medical UK Limited, with plans to establish a direct sales presence within the United Kingdom (UK) and Ireland. ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it has received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 Net Operating Loss (NOL) and R&D tax credits from the ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it is now taking pre-orders for Biotres, the Company’s three-lead device designed to continuously record electro-cardiogram (ECG) data for early detection of cardiac arrhythmias. The Company believes that its wireless, ...
The HD Steth provides medical professionals with access to patented algorithms and High-Definition visualization and noise-cancellation technologies that support instantaneous diagnosis by a remote specialist, leveraging the power of AI and predictive analytics in both the HD Steth and the HD Steth app as well as in the cloud delivering connected, collaborative care. ...
Jennifer Cowger, Medical Director of the Mechanical Circulatory Support Program and Co-Director of the Cardiac Intensive Care Unit at Henry Ford Hospital in Detroit, MI. “After completing therapy, the patient showed significant improvement in the key hemodynamic parameters, shed over 10 liters of excess fluid, and greatly improved creatinine levels, a ...
” “The work the Elucid team is doing has the potential to change the standard of care for cardiac and neurovascular patients, resulting in cost savings and superior outcomes by enabling precision medicine,” said Dr. ...
ByElucid
Ultimately, this early detection could help push care delivery away from its reactive model, reducing costs and drastically improving the quality of life for patients dealing with chronic ...
Vizient awards Innovative Technology contracts for technologies that demonstrate an ability to enhance clinical care and reduce the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety. ...